Let's Have One More Look on the Potential Power of Dynamic Susceptibility Contrast MRI: Time, Space, and Vascular Habitats in Locally Recurrent High-grade Gliomas
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Juan-Albarracin J, Fuster-Garcia E, Perez-Girbes A, Aparici-Robles F, Alberich-Bayarri A, Revert-Ventura A
. Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival. Radiology. 2018; 287(3):944-954.
DOI: 10.1148/radiol.2017170845.
View
2.
Qazi M, Vora P, Venugopal C, Sidhu S, Moffat J, Swanton C
. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Ann Oncol. 2017; 28(7):1448-1456.
DOI: 10.1093/annonc/mdx169.
View
3.
Ringel F, Pape H, Sabel M, Krex D, Bock H, Misch M
. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol. 2015; 18(1):96-104.
PMC: 4677413.
DOI: 10.1093/neuonc/nov145.
View
4.
Aquino D, Gioppo A, Finocchiaro G, Bruzzone M, Cuccarini V
. MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives. J Immunol Res. 2017; 2017:5813951.
PMC: 5415864.
DOI: 10.1155/2017/5813951.
View
5.
Wen P, Weller M, Quant Lee E, Alexander B, Barnholtz-Sloan J, Barthel F
. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020; 22(8):1073-1113.
PMC: 7594557.
DOI: 10.1093/neuonc/noaa106.
View